You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

PTAB Cases by Type: Inter partes review


✉ Email this page to a colleague

« Back to Dashboard


Patent Trial and Appeal Board Cases by Type: Inter partes review

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,716,830 Apotex Inc. ⤷  Sign Up 2012-10-05 10-04-2012 Alcon Pharmaceuticals Ltd. Inter partes review ⤷  Sign Up 03-19-2013 Gerald Cagle ⤷  Sign Up
7,671,070 Apotex Inc. ⤷  Sign Up 2012-10-12 10-12-2012 Alcon Inter partes review ⤷  Sign Up 03-19-2013 Gerald Cagle ⤷  Sign Up
6,436,989 Ranbaxy Laboratories Ltd. et al. ⤷  Sign Up 2012-10-18 10-18-2012 Vertex Pharmaceuticals Incorporated Inter partes review ⤷  Sign Up 03-05-2013 MICHAEL HALE ⤷  Sign Up
8,212,094 Syntroleum Corporation ⤷  Sign Up 2013-03-08 03-08-2013 Neste Oil OYJ Inter partes review ⤷  Sign Up 09-04-2013 Jukka MYLLYOJA ⤷  Sign Up
7,772,209 Accord Healthcare, Inc., USA ⤷  Sign Up 2013-06-14 06-14-2013 Eli Lilly and Company Inter partes review ⤷  Sign Up 10-01-2013 Clet Niyikiza ⤷  Sign Up
8,206,740 Amneal Pharmaceuticals, LLC et al. ⤷  Sign Up 2013-06-20 06-20-2013 Supernus Pharmaceuticals, Inc. Inter partes review ⤷  Sign Up 12-17-2013 Rong-Kun Chang ⤷  Sign Up
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.